Alpha-Tryptase Overexpression as a Modifier of Mast Cell–Mediated Reactions
- 25 October 2025
- journal article
- review article
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 13 (12) , 3180-3186
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases (4R00AI138586)
- The Slovenian Research and Innovation Agency (J3-50099)
This publication has 62 references indexed in Scilit:
- Alpha-Tryptase as a Risk-Modifying Factor for Mast Cell–Mediated ReactionsCurrent Allergy and Asthma Reports, 2024
- Hereditary alpha-tryptasemia despite normal tryptase-encoding gene copy number owing to copy number loss in transAnnals of Allergy, Asthma & Immunology, 2021
- Inherited and acquired determinants of serum tryptase levels in humansAnnals of Allergy, Asthma & Immunology, 2021
- Global View on Ant Venom Allergy: from Allergenic Components to Clinical ManagementClinical Reviews in Allergy & Immunology, 2021
- Hereditary alpha-tryptasemia in 101 patients with mast cell activation–related symptomatology including anaphylaxisAnnals of Allergy, Asthma & Immunology, 2021
- Hereditary Alpha-Tryptasemia: a Commonly Inherited Modifier of AnaphylaxisCurrent Allergy and Asthma Reports, 2021
- Hereditary Alpha TryptasemiaImmunology and Allergy Clinics of North America, 2018
- First Identification of an Inherited TPSAB1 Quintuplication in a Patient with Clonal Mast Cell DiseaseJournal of Clinical Immunology, 2018
- Clinical characteristics and risk profile of patients with elevated baseline serum tryptaseAllergologia et Immunopathologia, 2014
- Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosisAmerican Journal of Hematology, 2014